Search results - 5 results
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
of large-scale randomised trials support initiation of HPV-based screening from age 30 years and extension of screening intervals to at least 5 years. FUNDING: European Union, Belgian Foundation ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Vaccination Young adult Abstract: Limited data are available on the burden of human papillomavirus (HPV) and its associated diseases in the Russian Federation, the Western Countries of the former Soviet Union ...
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
Invasiveness Prognosis Risk Factors Romania Survival Rate Uterine Cervical Neoplasms Young adult Abstract: The burden of cervical cancer varies considerably in the European Union (EU). In this article, we ...
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document.
are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured ...
Burden of cervical cancer in Europe: estimates for 2004.
deaths, the standardised and cumulative rates (up to age of 74 years) were computed for individual countries, and aggregated for the 15 old (EU15) and the 10 new member states (EU10) of the European Union ...